SCHEMBL25041340

SCHEMBL25041340

O=C(O)CCOCCOCCOCCOCCNCO

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
CD274 Q9NZQ7 2/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 2/20 0.32
USP2 O75604 1/20 0.32
ALKBH5 Q6P6C2 1/20 0.32
SUCNR1 Q9BXA5 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
CAMK2A Q9UQM7 1/20 0.31
TSHR P16473 2/20 0.31
TLR2 O60603 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17229458 0.89 SMN1; SMN2 (0.38) SMN1; SMN2CD274KDM4EALDH1A1MEN1
SCHEMBL18882749 0.89 SMN1; SMN2 (0.38) SMN1; SMN2CD274KDM4EALDH1A1MEN1
SCHEMBL17089915 0.89 SMN1; SMN2 (0.38) SMN1; SMN2CD274KDM4EALDH1A1MEN1
SCHEMBL30433408 0.89 SMN1; SMN2 (0.38) SMN1; SMN2CD274KDM4EALDH1A1MEN1
Hydrochloric Acid SCHEMBL26689478 0.87 SMN1; SMN2 (0.37) SMN1; SMN2CD274KDM4EALDH1A1MEN1
SCHEMBL7720634 0.87 LTA4H (0.36) SMN1; SMN2CD274MEN1KMT2ABLM
SCHEMBL7191311 0.87 LMNA (0.38) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL29004037 0.82 LMNA (0.37) SMN1; SMN2CD274KDM4EALDH1A1MEN1
SCHEMBL23748106 0.82 MEN1 (0.37) SMN1; SMN2CD274KDM4EALDH1A1MEN1
SCHEMBL21806634 0.82 MEN1 (0.37) SMN1; SMN2CD274KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023016999-A2 Compounds Cargene Therapeutics Pte. Ltd. (SG) 2023-02-16 WO disclosed